| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.009 | 1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |